- Home
- IMMP vs CIA Comparison
IMMP vs CIA Comparison
Compare IMMP & CIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- CIA
- Stock Information
- Founded
- IMMP 1987
- CIA 1969
- Country
- IMMP Australia
- CIA United States
- Employees
- IMMP N/A
- CIA N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- CIA Life Insurance
- Sector
- IMMP Health Care
- CIA Finance
- Exchange
- IMMP Nasdaq
- CIA Nasdaq
- Market Cap
- IMMP 251.8M
- CIA 261.8M
- IPO Year
- IMMP N/A
- CIA N/A
- Fundamental
- Price
- IMMP $1.64
- CIA $5.46
- Analyst Decision
- IMMP Buy
- CIA
- Analyst Count
- IMMP 1
- CIA 0
- Target Price
- IMMP $7.00
- CIA N/A
- AVG Volume (30 Days)
- IMMP 87.8K
- CIA 141.9K
- Earning Date
- IMMP 10-21-2025
- CIA 11-06-2025
- Dividend Yield
- IMMP N/A
- CIA N/A
- EPS Growth
- IMMP N/A
- CIA N/A
- EPS
- IMMP N/A
- CIA 0.22
- Revenue
- IMMP $3,306,742.00
- CIA $245,943,000.00
- Revenue This Year
- IMMP N/A
- CIA $4.22
- Revenue Next Year
- IMMP $725.37
- CIA $4.46
- P/E Ratio
- IMMP N/A
- CIA $24.78
- Revenue Growth
- IMMP 31.28
- CIA N/A
- 52 Week Low
- IMMP $1.32
- CIA $2.90
- 52 Week High
- IMMP $2.71
- CIA $5.95
- Technical
- Relative Strength Index (RSI)
- IMMP 46.06
- CIA 63.72
- Support Level
- IMMP $1.60
- CIA $5.04
- Resistance Level
- IMMP $1.68
- CIA $5.44
- Average True Range (ATR)
- IMMP 0.07
- CIA 0.16
- MACD
- IMMP -0.00
- CIA -0.03
- Stochastic Oscillator
- IMMP 28.12
- CIA 100.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About CIA Citizens Inc. ($1.00 Par)
Citizens Inc is an insurance holding company serving the life insurance needs of individuals in the United States. The company provides insurance benefits to residents in thirty two U.S. states and more than seventy countries through its insurance subsidiaries. The company operates in two business segments namely the Life Insurance segment and the Home Service Insurance segment. The company majority generates revenues from Life Insurance segment. Company operates in USA, Columbia, Taiwan, Venezuela, Ecuador, Argentina, and Others.